During virus assembly, HIV-1 Gag-Pol is packaged into virions via interaction with Pr55gag. Studies suggest that Gag-Pol by itself is incapable of virus particle assembly or cell release, perhaps due to the lack of a budding domain in the form of p6gag, which is truncated within Gag-Pol because of a ribosomal frameshift during Gag translation. Additionally (or alternatively), large molecular size may not support Gag-Pol assembly into virus-like particles (VLPs) or release from cells. To test these hypotheses, we constructed Gag-Pol expression vectors retaining and lacking p6gag, and then reduced Gag-Pol molecular size by removing various lengths of the Pol sequence. Results indicate that Gag-Pol constructs retaining p6gag were capable of forming VLPs with a WT HIV-1 particle density. Gag-Pol molecular size reduction via partial removal of the Pol sequence mitigated the Gag-Pol assembly defect to a moderate degree. Our results suggest that the Gag-Pol assembly and budding defects are largely due to a lack of p6gag, but also in part due to size limitation.
ChiuH. C., YaoS. Y., WangC. T.2002; Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160gag-pol into virus particles. J Virol 76:3221–3231 [View Article][PubMed]
ChungH.-Y., MoritaE., von SchwedlerU., MüllerB., KräusslichH.-G., SundquistW. I.2008; NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol 82:4884–4897 [View Article][PubMed]
DoyonL., PayantC., Brakier-GingrasL., LamarreD.1998; Novel Gag-Pol frameshift site in human immunodeficiency virus type 1 variants resistant to protease inhibitors. J Virol 72:6146–6150[PubMed]
GöttlingerH. G., SodroskiJ. G., HaseltineW. A.1989; Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 86:5781–5785 [View Article][PubMed]
HaraguchiH., NodaT., KawaokaY., MorikawaY.2012; A large extension to HIV-1 Gag, like Pol, has negative impacts on virion assembly. PLoS One 7:e47828 [View Article][PubMed]
JacksT., PowerM. D., MasiarzF. R., LuciwP. A., BarrP. J., VarmusH. E.1988; Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331:280–283 [View Article][PubMed]
KaplanA. H., ZackJ. A., KniggeM., DA., KempfD. J., NorbeckD. W., SwanstromR.1993; Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J Virol 67:4050–4055[PubMed]
KaracostasV., WolffeE. J., NagashimaK., GondaM. A., MossB.1993; Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193:661–671 [View Article][PubMed]
KohlN. E., EminiE. A., SchleifW. A., DavisL. J., HeimbachJ. C., DixonR. A., ScolnickE. M., SigalI. S.1988; Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A 85:4686–4690 [View Article][PubMed]
LiaoW.-H., WangC.-T.2004; Characterization of human immunodeficiency virus type 1 Pr160gag-pol mutants with truncations downstream of the protease domain. Virology 329:180–188 [View Article][PubMed]
PageK. A., LandauN. R., LittmanD. R.1990; Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol 64:5270–5276[PubMed]
ParkJ., MorrowC. D.1991; Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J Virol 65:5111–5117[PubMed]
PengC., HoB. K., ChangT. W., ChangN. T.1989; Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol 63:2550–2556[PubMed]
PettitS. C., Moody, M.D., WehbieR. S., KaplanA. H., NantermetP. V., KleinC. A., SwanstromR.1994; The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol 68:8017–8027[PubMed]
PettitS., EverittL., ChoudhuryS., DunnB., KaplanA.2004; Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. J Virol 78:8477–8485 [View Article][PubMed]
RoyerM., BardyM., GayB., TournierJ., BoulangerP.1997; Proteolytic activity in vivo and encapsidation of recombinant human immunodeficiency virus type 1 proteinase expressed in baculovirus-infected cells. J Gen Virol 78:131–142 [View Article][PubMed]
SmithA. J., SrinivasakumarN., HammarskjöldM. L., RekoshD.1993; Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J Virol 67:2266–2275[PubMed]
SrinivasakumarN., HammarskjöldM. L., RekoshD.1995; Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol 69:6106–6114[PubMed]
SwanstromR., WillsJ.1997; Synthesis, assembly and processing of viral proteins. In Retroviruses pp 263–334Edited byCoffinJ., HughesS., VarmusH. Cold Spring Harbor, NY:: Cold Spring Harbor Laboratory Press;